Our 2024 announcement of the results of joint study with Dr. Alejandro Ocampo:
YouthBio Therapeutics Announces Significant Results from Joint Study with Dr. Ocampo Demonstrating Amelioration of Age-Related Cognitive Decline

A 2023 paper by João Pedro de Magalhães:
Ageing as a software design flaw

A 2023 interview with Yuri Deigin:
Meet the founder: Yuri Deigin

A 2022 interview with João Pedro de Magalhães by Lifespan.io:
João Pedro de Magalhães on Reprogramming and Aging Theories

A 2022 paper by João Pedro de Magalhães and Alejandro Ocampo:
Cellular reprogramming and the rise of rejuvenation biotech

A 2022 interview with Yuri Deigin by Lifespan.io:
Yuri Deigin on Cellular Reprogramming in Humans

A 2022 video interview with Yuri Deigin on partial reprogramming
Cognitum S2 Episode 6 // Epigenetic Rejuvenation

A 2022 profile by Longevity.Technology:
YouthBio CEO: The time is right to develop epigenetic reprogramming therapies

Our announcement about emergence out of stealth:
YouthBio Therapeutics Exits Stealth Mode – PR Newswire
YouthBio Therapeutics: New epigenetic rejuvenation startup emerges from stealth

An overview of the partial reprogramming startup landscape from Nature:
Rejuvenation by controlled reprogramming is the latest gambit in anti-aging